|
|
||||||||
Departments of 1 Internal Medicine (Pulmonary and Critical Care Division) and 2 Emergency Medicine, Dorothy Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio 43210
| |
ABSTRACT |
|---|
|
|
|---|
Intermittent hypoxia (IH) describes conditions of repeated, transient reductions in O2 that may trigger unique adaptations. Rest periods during IH may avoid potentially detrimental effects of long-term O2 deprivation. For skeletal muscle, IH can occur in conditions of obstructive sleep apnea, transient altitude exposures (with or without exercise), intermittent claudication, cardiopulmonary resuscitation, neonatal blood flow obstruction, and diving responses of marine animals. Although it is likely that adaptations in these conditions vary, some patterns emerge. Low levels of hypoxia shift metabolic enzyme activity toward greater aerobic poise; extreme hypoxia shifts metabolism toward greater anaerobic potential. Some conditions of IH may also inhibit lactate release during exercise. Many related cellular phenomena could be involved in the response, including activation of specific O2 sensors, reactive oxygen and nitrogen species, preconditioning, hypoxia-induced transcription factors, regulation of ion channels, and influences of paracrine/hormonal stimuli. The net effect of a variety of adaptive programs to IH may be to preserve contractile function and cell integrity in hypoxia or anoxia, a response that does not always translate into improvements in exercise performance.
altitude; ion transport; preconditioning; antioxidant; free radicals; reactive oxygen; obstructive sleep apnea; peripheral vascular occlusive disease; citrate synthase; cytochrome oxidase; myosin heavy chain
| |
INTRODUCTION |
|---|
|
|
|---|
THE TERMS, INTERMITTENT HYPOXIA (IH), periodic hypoxia, and episodic hypoxia have been used to describe conditions of repeated, transient reductions in O2 that may play a role in triggering the responses to certain environmental or pathological conditions. When applied to the special case of tissues with a high metabolic rate relative to blood flow, such as cardiac or exercising skeletal muscle, intermittent tissue hypoxia can exist in the absence of reductions in arterial PO2 (PaO2). In such cases, capillary O2 supply fails to match metabolic demands, resulting in transient, localized hypoxia in the muscle cells or in the mitochondrial microenvironment.
We know very little about the level of cellular hypoxia in muscle required to trigger adaptive responses to IH. In fact, we know very little about IH. With a few exceptions (see, e.g., Refs. 12, 39, 83, 84), the actual stimulus within the muscle is rarely measured in vivo. Most studies have relied on descriptions of PaO2, inspired O2 fraction, or altitude as the stimulus modality. However, even tissue PO2 or myoglobin O2 saturation can only approximate the intracellular signal, particularly when hypoxia or ischemia are transient and coupled with varying contractile activity, where increasing intracellular O2 diffusion gradients and heterogeneity would be expected (50).
The hypoxic stimulus as viewed by the cell is complex. Two broad
categories of cell hypoxia have been defined by Connett et al.
(20): "adapted cell hypoxia" and "dysoxia" (Fig.
1). Adapted cell hypoxia describes a
level in which O2 availability is nonsaturating for
cytochrome oxidase (COX), but metabolic adaptations compensate to
maintain ATP flux via aerobic metabolism (20). In
contrast, dysoxia exists when the ability of the mitochondrial
cytochromes to reduce O2 to H2O is substrate
limited by O2 availability, resulting in the need for
supplemental glycolysis to support ATP production (20).
Given sufficient time, dysoxia can lead to compromised function or even
cell death in tissues of homeotherms, although certain heterotherms can
survive dysoxia almost indefinitely (47). In trying to
understand the adaptive responses to hypoxia, it is likely that
different levels of PO2 are sensed by the cell. This may result in a graded recruitment of cell programs or simple enzyme responses that initiate unique strategies suited to optimizing ATP flux in specific O2 environments.
|
Why would the responses to IH differ from chronic hypoxia? In many cases, it is highly likely that the responses overlap, particularly when describing their effects on skeletal muscles. However, whereas long-term exposure to severe hypoxia can progress to cell injury and deterioration (14, 35), short-term exposures may be of sufficient amplitude to initiate adaptive responses while providing periods of recovery that avoid the injurious effects of O2 deprivation (Fig. 1). In addition, there may be unique physiological signals associated with transitions between hypoxia and reoxygenation, such as the formation of reactive oxygen species (ROS) (22, 95, 100, 102) or facilitation of sympathetic outflow (27, 92, 96) and other reflex pathways (67, 78), that can induce their own physiological responses.
There are a number of clinical or environmental conditions that are referred to as producing conditions of IH, including obstructive sleep apnea (OSA) (80), transient exposures to high altitude (with and without exercise) (34, 63, 110), intermittent claudication (12, 24, 53), exercise in diseases with compromised O2 delivery such as chronic lung disease or heart failure (33) events that obstruct placental blood flow (100), some unique conditions of myocardial infarction (32), and the diving responses of marine mammals (25). It is very unlikely that these diverse conditions result in identical cellular adaptations. In each, there are marked differences in the timing of hypoxic cycling, the length of exposure, and the degree of hypoxia with each cycle. Any of these variables could influence the pattern of response. There may also be important costimuli, such as PCO2, acidosis or alkalosis, and metabolite or nitric oxide (NO) accumulation, which vary depending on whether the hypoxia is induced by alterations in environmental PO2, apnea, or ischemia. However, all of these conditions are conceptually linked. Clearly, more specific definitions would be useful.
| |
MODELS OF IH |
|---|
|
|
|---|
Table 1 summarizes the terms used in
this review. The term IH will describe conditions of hypoxia in which
PCO2 is allowed to remain at normal levels or
to decrease with ventilatory responses to chemoreceptor stimulation.
This condition is typical of brief exposures to altitude. Intermittent
asphyxia (IA) will be used to describe conditions in which hypoxia is
accompanied by hypercapnia, usually due to lack of effective
ventilation, such as in OSA. Intermittent ischemia (IIsch)
describes conditions in which lack of effective blood flow induces
transient conditions of hypoxia and hypercapnia and retention of
metabolites. These categories can be further refined with the
descriptive terms short cycle and long cycle, which will refer to
conditions of hypoxic cycling in periods of <5 min and >5 min,
respectively.
|
Much of IH research regarding long-cycle IH has been driven by interest in understanding altitude physiology, particularly the potential for exercise at altitude to influence athletic performance (6, 57, 62, 63). The lines between IH and chronic hypoxia in these models are often obscured. For example, intermittent bouts of exercise at altitude, as might occur during mountain climbing, may represent a superimposed IH-like stimulus on top of a chronic hypoxia stimulus. Furthermore, some of the models of long-cycle IH provide a hypoxic stimulus for as long as 12 h/day, which may approach a chronic hypoxic environment (73-75). Still other models of continuous altitude acclimatization are performed at altitudes low enough that it is likely muscles are exposed to significant hypoxia only during exercise (57, 63).
In contrast, short-cycle oscillations in inspired O2 are often used to model OSA (see, e.g., Refs. 17, 28, 92). This stimulus influences blood pressure (28), sympathetic control (92, 96), and ventilatory drive (53), responses mediated largely by oscillatory stimulation of the arterial chemoreceptors. There are differences, however, when considering such stimuli in muscle cells. Chemoreceptors are presumably capable of seeing the wave forms of PaO2 with reasonable fidelity because of their high blood flow relative to metabolic rate. Such oscillations at muscle cells and muscle mitochondria are more likely damped by local metabolic autoregulation of blood vessels and capacitor-like behavior of O2 storage systems (membranes and myoglobin). Therefore, in muscle cells, rapid oscillations in PaO2 may be seen as much slower wave forms with lower amplitude.
| |
ULTRASTRUCTURAL ADAPTATIONS |
|---|
|
|
|---|
Although there is little conclusive evidence for ultrastructural and phenotypic changes in response to moderate IH, IIsch, and IA, there is some evidence in more severe conditions (18, 98). For example, no changes have been noted in intermittent exercise training at altitude (a model of IH) (62), in animal models of arterial insufficiency (41), in models of short-cycle IH (17), or in moderate peripheral occlusive disease in humans (98). However, as the severity of arterial occlusive disease worsens, the gastrocnemius muscle increases the percentage of type I myosin heavy chain (MHC) (98), characteristic of a shift to slow-oxidative fiber types. This is accompanied by decreases in type IIb MHC and eventual loss of type IIa MHC (98). Clyne et al. (18) reported somewhat contrasting results in this population using fiber typing. They observed a general loss of fiber cross-sectional area across the whole population of type I and II myocytes and attributed this to deconditioning. The changes in MHC seen in the gastrocnemius (98), however, are not particularly consistent with deconditioning (77). They represent an interesting deviation from the response pattern seen in altitude acclimatization (35), disorders of gas exchange such as obstructive lung disease (60), or congestive heart failure (33, 106).
Chronic hypoxia induces quite specific ultrastructural modifications. There is a generalized muscle wasting and loss of cross-sectional area of all fiber types (14, 35). This is also reflected in a loss of muscle mass in the thigh (7) and no doubt contributes to a reduction in the maximum O2 uptake measured in acclimatized subjects on return to sea level (15). It has been suggested that these responses are a form of muscle deterioration (14), but an argument can be made that the loss of mass is part of a programmed constellation of normal adaptive responses that minimize diffusion distances. For example, in some models of altitude acclimatization, capillary density appears to increase due to reductions in fiber cross-sectional area rather than angiogenesis (4, 63, 93). Mitochondrial volume density often decreases with altitude (45), but there are no apparent changes in the proportions of type I and II fiber types (35).
| |
METABOLIC ADAPTATIONS |
|---|
|
|
|---|
Metabolic responses to various forms of IH in intact mammals do not comprise a single pattern of adaptation. Furthermore, there are also no clear distinctions from chronic hypoxic stimuli. The combined complexity and universality of the response may reflect the evolutionary importance of hypoxic adaptation, as primitive organisms developed responses comprising a variety of long- and short-term strategies to sustain energy flux in widely varying PO2. Unfortunately, the data we have to work with in understanding metabolic adaptations of intact, higher organisms are restricted to single, pooled samples of in vitro enzyme activities, high-energy phosphates, and substrate/metabolite concentrations from heterogeneous muscles. Clearly, a great deal of noise is inherent in these measurements, and there is much disagreement in the literature. However, some interesting patterns of response emerge.
Oxidative metabolism.
In models of both chronic hypoxia and IH, there appear to be biphasic
responses of metabolic enzyme activities involved in the Krebs cycle
and possibly electron transport. Figure
2A summarizes data from a
large number of studies (34-36, 44, 45, 62, 73-75, 86,
110) on animals and humans subjected to both intermittent and
chronic hypoxia. Changes in oxidative enzyme activity are expressed as
percent changes in Krebs cycle enzymes [usually citrate synthetase
(CS)] from controls. We have combined both IH and chronic hypoxia in
this analysis for purposes of discussion. As shown, whether the hypoxic
stimulus is intermittent or chronic, very low levels of inspired
O2 exposure result in a general loss of Krebs cycle enzyme
activity. In contrast, at more modest levels of hypoxia, somewhere
above an atmospheric PO2 of 80-100
Torr, stimulations of aerobic enzyme activities are evident
(34, 35, 62), particularly when coupled with exercise
(34, 62). Please note that considerable liberties were
taken in generating the relationship in Fig. 2. Not only are there
widely varying intermittent and chronic hypoxia paradigms and species
but variables that have been demonstrated to influence enzyme activity
were not factored in. These include days of exposure to either IH
(44, 74, 75) or chronic hypoxia (79), the
level of exercise conditioning during exposure (34, 62,
63), and age (73). Nevertheless, the relationship
seems to suggest a biphasic pattern of response in which strategies
promoting stimulation of oxidative capacity are reversed at a critical
PO2.
|
Glycolytic enzymes.
Characteristic changes in lactate dehydrogenase (LDH) activity using a
variety of models of chronic hypoxia and IH exposure (35, 45, 73,
74, 74, 75, 110) are shown in Fig.
3A. LDH is discussed here
because it is one of the more frequently measured enzyme activities
related to glycolysis, and data for other enzymes such as
phosphofructokinase (PFK) are less abundant in the literature. In
addition, the ratio of LDH to CS has been used as a general indicator
of adjustments to relative anaerobic/aerobic potential
(43). The same caveats apply for this summary of data as
in Fig. 2. However, generally, in most studies of humans exposed to
chronic hypoxia, there is little or no appreciable shift in LDH
activity (35, 45, 86). Other enzyme activities in the glycolytic pathway such as PFK may actually drop (36) or
increase (45), depending on the experiment. In contrast,
in long-cycle IH models in rats, large increases of LDH are
apparent, which are exactly out of phase with the decreases
seen in aerobic enzyme activities shown in Fig. 2A.
Resultant changes in LDH/CS suggest that, in severe IH, there is a
shift to greater anaerobic/aerobic potential.
|
Glucose and glycogen. The transport of glucose, its phosphorylation, and the ability to store and utilize glycogen are other adaptations of known importance to the cell's response to acute hypoxia. In eleven of the samples of IH and continuous hypoxia illustrated in Figs. 1 and 2, nine showed increases or trends suggesting elevations in hexokinase (HK) activity, a measure of early events in glucose utilization. Two showed little or no change or trends toward a decrease (35, 45). In at least one model of arterial insufficiency in the rat, there are marked increases in HK activity in mixed, slow-twitch, and fast-twitch muscles of the hindlimb after 7 days of femoral ligation (41). However, in human arterial insufficiency, no remarkable changes in HK have been observed (11). It has been suggested that the increase in HK activity is related to greater dependence on glucose with adaptation to hypoxia (9).
We simply do not have enough information about glucose transport in models of IH to draw significant conclusions. It may be an interesting area of research because glucose transport in hypoxia involves pathways that are activated somewhat differently from insulin or contractile-dependent changes in uptake (107, 109). Furthermore, hypoxia-induced transcription factors (HIF-1
)
upregulate glucose transport proteins (Glut1 and Glut3)
(10). It is worth mentioning that hypoxia-induced glucose
uptake during contractions is, in part, adenosine dependent, which
means that important regulating signals might be different from those
in IH, in which washout of adenosine would be high (52),
vs. those in IIsch or arterial insufficiency, in which adenosine would
accumulate in the tissue (21).
Although there has been no study to our knowledge of the influence of
IH on glycogen utilization and storage, there have been recent studies
in hearts exposed to brief periods of IA (61). Withdrawal
of mechanical ventilation and clamping of the airway for 90-s periods,
separated by 5-min intervals of ventilation, caused activation of
glycogen synthase and rapid accumulation of glycogen immediately after
hypoxia (61). The signal for this alteration appears to be
directly related to glycogen breakdown during hypoxia
(61). It is unknown whether more long-term adaptations occur to glycogen synthesis in response to IH.
The "lactate paradox." Exercise during acute hypoxia results in stimulation of lactic acid production compared with the same exercise performed during normoxia. However, after acclimatization to altitude, the lactic acid production is markedly attenuated, in both muscle and blood compared with acute exposure (5, 36, 37, 62). This phenomenon has been called the lactate paradox (42), but it may not be unique to chronic hypoxia exposure or altitude acclimatization. Similar responses are seen in conditions of IA (105). For example, in patients with OSA, maximal lactate concentrations in exercise are ~60% of those seen in control subjects (105) in a condition in which elevated diastolic pressures, normal maximum heart rates, and a propensity toward deconditioning are prevalent. In conditions of IIsch, such as exercise with arterial insufficiency, lactate measurements in muscle achieve high levels during exercise (13). This may reflect metabolite accumulation because, when measurements of rates of release are calculated, muscles undergoing combined stimulation and ligation show decreased lactate release compared with stimulation in the unligated, contralateral leg (23). It seems reasonable to speculate that lactate paradox may be a generalized phenomenon, common to many forms of adaptation to hypoxia.
A number of mechanisms have been suggested to account for lactate paradox. These include 1) decreased glycolytic flux (8), 2) decreased glycogen storage (105), 3) changes in buffering capacity (14, 63), 4) changes in efficiency of muscle contraction (105), and 5) improved coupling between oxidative phosphorylation and glycolytic flux (36). The mechanism in OSA or arterial insufficiency has not been evaluated, but it is well known that in patients with OSA and in models of IH there is an overall stimulation of the sympathetic outflow, resulting in systemic hypertension (27, 66). The increased circulating epinephrine could potentially inhibit glycogen synthetase (29). Because it has been estimated that 99% of the glucose that is made available for glycolysis during exercise comes from glycogen stores (54), reduction of glycogen stores could depress glycolytic flux during exercise. Exercise responses in subjects acclimatized to altitude show a glycogen sparing effect that would also be consistent with this mechanism (36). The role of buffering capacity on glycolytic control is related to the fact that one of the primary rate-limiting enzymes in glycolysis, PFK, is inhibited by acidosis (97). In altitude acclimatization, there is a loss of buffering capacity of the blood due to HCO

| |
OTHER ADAPTIVE RESPONSES |
|---|
|
|
|---|
Ion transport. Recently, Green et al. (34) have shown that, when intermittent exercise training is conducted in hypoxia, there is a downregulation of Na+-K+- ATPase pump expression in limb muscle, which is in contrast to exercise training alone (34). The significance of this finding is not known, but the important role of ion gradients in sustaining membrane potential and the possible influence of extracellular K+ on contractile function during high-frequency fatigue have been emphasized (70) . In heart muscle, enzyme studies on membrane-bound Mg2+, Ca2+, and Na+-K+-ATPases showed no change in maximum activity but a lowering of the Km, signifying an increased enzyme affinity for the substrate (112). This effect could slow the rate of decline of enzyme activity in severe hypoxic exposures.
In a recent study of short-cycle IH in the rat (17), marked changes in twitch contraction characteristics were observed in isolated diaphragm with no changes in maximum force generation. Increases in passive tension (contracture), normally observed during exposure to anoxia, were completely inhibited in the IH-treated rats. Although there are many potential mechanisms for these findings, one intriguing possibility is that membrane ion channel and pump functions were altered by IH, affecting ion movements during normoxic conditions and preserving membrane potential and preventing Ca2+ leakage during hypoxia.O2 transport. There is very little information regarding changes in myoglobin content in models of IH or adaptive changes in the capacity to deliver O2. Humans native to high-altitude environments show myoglobin contents in the sartorius ~16% above those of natives of similar ethnicity living at sea level (82). How rapidly these changes occur or whether they occur in IH are not known. At 5,100 m, it requires 14 wk for myoglobin to be significantly elevated in guinea pig soleus muscle (93).
Recent studies have also hypothesized that O2 distribution in highly metabolic tissue may be affected by NO generated in the capillary endothelium (101) or possibly from the myocytes themselves. Gradients of NO, radiating from the vessel, are believed to inhibit mitochondrial respiration in locations of high PO2, close to the vessel, thus preserving O2 gradients for mitochondria at greater distances (101). This effect could be amplified in acute ischemia because of NO accumulation. Furthermore, it could also be amplified in chronic hypoxic exposures, as it has been shown that one of the adaptive responses to chronic hypoxia in muscle is upregulation of endothelial and neuronal isoforms of nitric oxide synthase (48). However, this concept has not been tested in IH and cannot explain improved function in anoxia (17).Autocrine/paracrine influences. Global IH has a number of influences on circulating hormones and local metabolites that could play important roles in adaptive responses of muscle to IH. Little is known about the significance of these signals, but the issue is raised here to illustrate the complexity of the stimulus and to inspire future work. The possibility that IH-induced elevations in sympathetic tone, specifically epinephrine release, can affect glycogen storage has been mentioned. However, epinephrine can also stimulate cAMP in muscles, which could have secondary effects on multiple metabolic and cell signaling pathways (see, e.g., Refs. 40, 68). Sleep apnea has also been found to induce the release of endogenous digitalis-like factors that directly inhibit Na+-K+-ATPase (71). Leptin levels are increased in patients with OSA, beyond the levels measured in similarly obese individuals (78). Leptin is produced by adipose tissue and is involved in a number of physiological feedback loops, including inhibition of appetite (90) and stimulation of metabolism (46). Atrial natriuretic peptide (ANP) release is increased in patients with OSA (56), and, in animal models of short-cycle IH, mRNA for both A and B type ANP is increased in right and left ventricles (55). Other interesting paracrine effects may arise from endothelial cells. Hypoxic endothelial cells release low-molecular-weight peptides in response to hypoxia that directly inhibit the unloaded shortening velocity of skinned soleus muscles and depress in vitro cardiac myosin ATPase activity (91). It is interesting to note that cardiac myofibril ATPase activity is reduced in animals exposed to intermittent altitude (76). Furthermore, adenosine, released during hypoxia and ischemia, can have many local paracrine and autocrine effects by stimulation of adenosine receptors on the cell membrane. Of particular importance may be its role as a "preconditioning" stimulus (19), as discussed below.
Overall effects of adaptation. The symphony of structural and enzymatic changes that occur in skeletal muscle can act as a reflection of hypoxia-induced disorders of metabolic regulation or could represent specific strategies designed to preserve contractile function and cell viability. Interestingly, this question has rarely been addressed in skeletal muscle. Recent results in isolated diaphragm favor the latter theory (17). After a 10-day exposure to short-cycle IH, contractile function of the diaphragm was greatly improved during anoxia and on reoxygenation compared with control animals (17). Resistance to hypoxia as an outcome variable could be differentiated from adaptive responses to exercise training, since no effects on strength (maximum force) or endurance of the diaphragm were seen (17).
Similar observations have been made from experiments in cardiac muscle in which intermittent exposure to hypoxia may reduce the risk of coronary heart disease and prevent the onset of arrhythmias (3, 81, 113). Cardiac myocytes exposed to 1% O2 for 48 h (which is described as providing full oxygenation) develop remarkable tolerance to subsequent hypoxias, showing delays in ATP depletion rigor and improved morphological recovery after reoxygenation (94).| |
CELL SIGNALING MECHANISMS OF ADAPTATION IN IH: FUTURE DIRECTIONS OF RESEARCH |
|---|
|
|
|---|
O2 sensors. Perhaps of all tissues in the body, skeletal muscles see the widest fluctuations in O2 demand and O2 delivery. Therefore, it would seem likely that they have developed sophisticated mechanisms for sensing changes in local O2 to which they could respond by regulating O2 demand and uptake, adjusting metabolic pathways and possibly initiating cell remodeling. Although the biology and biophysics of O2 sensors has been a proliferative area of research, it has not been studied in detail in skeletal muscle. A comprehensive review of O2 sensor biology exceeds the scope of this review, but molecules such as membrane NADPH oxidases, mitochondrial COX, a variety of K+ channels, metal-containing heme groups, or iron-sulfur clusters have all been implicated as molecular O2 sensors in various tissues and organisms (see, e.g., Refs. 10, 16, 30, 69, 79).
One apparent O2 sensor, which was recently described in skeletal muscle and which may have particular relevance to models of IH, is the Ca2+ release channel or ryanodine receptor. Eu et al. (26) have demonstrated that the ryanodine receptor is dramatically stimulated by dropping intracellular PO2 from ambient pressures to ~10 Torr. Although the mechanism is not completely worked out, it appears as though a specific thiol is nitrosylated in low O2. The nitrosylation occurs by reactions of available thiols with NO, but the local availability of NO and the responsiveness of the channel to nitrosylation are set by the PO2, i.e., the "responsiveness of the channel is thus tuned by the PO2" (26). This kind of a sensor could be activated by brief exposures to hypoxia and might be activated differently in conditions of ischemia (where NO dwell times are extended) or hypoxia-reoxygenation, which would favor an oxidizing environment. Such a mechanism could compensate for loss of contractile function due to metabolite feedback or low phosphorylation potential.Reactive oxygen as a signaling molecule in hypoxia. In recent years, a greater appreciation has emerged regarding the role of ROS and free radicals as signaling molecules in gene regulation (1). In sufficient concentration, they can, of course, cause a variety of degrees of oxidative damage. Although not generally appreciated, cell hypoxia, or ischemia alone, can result in the formation of low levels of ROS when the NADH/NAD+ reduction state of the cell is high and sufficient O2 is still available for single electron transfer. This phenomenon has been demonstrated most convincingly in isolated cardiac myocytes (22), but other studies in isolated hearts have drawn similar conclusions (72). Our laboratory observed such responses in isolated rat and mouse diaphragm as well (unpublished observations). The exact mechanism by which hypoxia induces ROS formation has not yet been identified in muscle. During reoxygenation, there is a secondary increase in ROS formation that is typical of hypoxia-reoxygenation and ischemia-reperfusion in a variety of organs (see, e.g., Refs. 31, 100, 104). That ROS have functional effects during hypoxia and reoxygenation in skeletal muscle is illustrated by the fact that antioxidant administration (particularly superoxide scavengers) results in marked improvements in contractile function during and after hypoxia (64). ROS formation is likely amplified by conditions of repeated hypoxia-reoxygenation exposure, at least in some tissues (see, e.g., Refs. 25, 31, 95, 100). However, in heart muscle, repeated exposures result in an attenuation of ROS formation (104). One striking example of the detrimental effects of repeated hypoxia-reoxygenation is revealed in the effects on neonatal brain cell viability after intermittent uterine ischemia-reperfusion, a model of eclampsia, or episodic contractions of labor (100). Repeated exposures cause marked oxidant injury and cell death in brain neurons, which is attenuated by antioxidant treatments. Indirect evidence in intact skeletal muscle that IIsch or IH produces ROS also comes from experiments using microdialysis of the redox state of glutathione (95). IIsch reduces the intracellular glutathione stores in muscle and results in active extrusion of oxidized glutathione from the tissue, thus reducing antioxidant defenses (95).
Is IH a sustained preconditioning stimulus? An attractive hypothesis regarding a potential pathway of adaptation is that IH stimuli induce a continuous state of preconditioning, protecting the muscle from subsequent exposures to ischemia. Preconditioning is a concept that arose in the cardiac literature (65) and has become a very large topic in the cardiobiology literature, well beyond the scope of this review (see reviews, Refs. 19, 108). However, several of the mediators discussed previously are known to play important roles in preconditioning. For example, ROS have been implicated by the fact that antioxidant treatments administered during ischemic preconditioning abolish the protective effects of preconditioning in heart muscle (103). Furthermore, preconditioning inhibits ROS formation in subsequent periods of ischemia-reperfusion (104). Likewise, treatment with adenosine induces an equally strong preconditioning-like influence in heart muscle that can be blocked by adenosine antagonists (87). These mediators may work in synchrony by activating protein kinase C pathways (19), upregulating antioxidant defenses (111), upregulating stress proteins (51), and the activating mitochondrial K+-ATP channels (87). Interestingly, the protective influence of chronic altitude exposure or chronic hypoxia appears to work by mechanisms that are additive to those induced by brief periods of ischemic preconditioning, suggesting that preconditioning and long-term hypoxia operate through parallel pathways (2, 99).
Hypoxia-induced gene expression in muscle.
Very little is known about how IH influences gene expression in muscle.
Recent studies of responses to acute hypoxia and exercise, however,
shed some light on possible pathways of adaptation (38, 84,
85). Gustafsson et al. (38) found that, in response to single exercise sessions with various levels of restricted blood
flow (IIsch), muscle hypoxia-inducible factors (HIF-1
, HIF-1
) and
vascular endothelial growth factor (VEGF) are dramatically increased.
The HIF-1
and -
transcription factors are necessary for VEGF
expression and are activated within a physiological
PO2 range consistent with exercising muscle
(49). Interestingly, the level of upregulation was
correlated to the femoral venous lactate concentration, suggesting a
relationship between tissue O2 uptake/delivery and gene
expression. Richardson et al. (84) demonstrated similar
findings in a model of hypoxia with exercise. However, in this study,
no significant amplification of VEGF mRNA was seen when hypoxia was
coupled with exercise compared with exercise in room air. Furthermore,
no relationship was observed with the level of muscle oxygenation
(84). Interestingly, after a period of exercise
conditioning, the increase in VEGF in response to exercise was greatly
diminished (85). This was used to support the idea that
the VEGF response system is tightly regulated. In the trained state,
when presumably capillarization and oxygenation are optimized, the
response appears to be attenuated by negative feedback mechanisms.
Would similar adaptive responses occur with long-term exposure to IH?
| |
SUMMARY AND CONCLUSIONS |
|---|
|
|
|---|
The primary distinguishing feature of IH, as it applies to skeletal muscle, is the presence of periods of recovery, providing windows of time for anabolic responses while avoiding the detrimental effects of long-term O2 deprivation (Fig. 1). At this time, there are no clear qualitative distinctions between the metabolic adaptations that occur between IH and chronic hypoxia in muscle. So far, experiments are consistent with the hypothesis that differences in response patterns between varying experimental paradigms predominantly reflect the magnitude and perhaps the duration of the hypoxic stimulus. Different levels of hypoxia may initiate different adaptive programs, possibly from stimulation of different molecular sensors with varying O2 affinities. Responses may be further influenced by exercise, either by direct effects on tissue oxygenation or intersection with other cell signaling networks. The predominant adaptive strategies at a given hypoxic exposure appear to be functionally related to the cell's capacity to extract available O2. For example, low levels of hypoxia or IIsch (particularly when coupled with exercise) facilitate aerobic metabolism, whereas more severe hypoxia (perhaps dysoxia) may favor upregulation of glycolysis. Very extreme, prolonged hypoxia can initiate catabolic processes that may purposefully be designed to improve O2 diffusion distance. The inhibition of lactic acid production appears to be a common feature of most forms of hypoxic adaptation, including IH, but it is possible that in different models, the strategies used to accomplish this are different. Although the inhibition of lactate production has sometimes been referred to as an "impairment to metabolism" (105), it is possible that it represents a mechanism by which the contractile and glycolytic inhibition associated with acidosis is prevented. It may also function to preserve the predominant flow of energy substrates to oxidative phosphorylation by improved coupling with glycolysis. Other pathways of adaptation, such as changes in the activities of membrane pumps or channels, changes in mechanisms of O2 storage or distribution, or influences of autocrine or paracrine signals, are not well defined.
Clearly, our understanding of IH or even chronic hypoxia in skeletal muscles is presently sketchy. It is our view that studying models of IH may reveal new information about hypoxic adaptation that would be distorted in studies of chronic exposure. In addition, studies of IH may make it possible to distinguish components of exercise adaptation that might be attributed to hypoxic signaling vs. pathways stimulated by contraction activity. Although considerable speculations regarding possible involvement of ROS, preconditioning stimuli, O2 sensors, hormonal/paracrine signaling, channel function, and growth factor gene expression were included in the review, it is our hope that this will stimulate interest and discussion in this area of research.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Valerie Wright for assistance in preparing the manuscript and John Merola for helpful discussions.
| |
FOOTNOTES |
|---|
The work was supported by National Heart, Lung, and Blood Institute Grant RO1-HL-53333. P. F. Klawitter was supported by a National Institutes of Health Research Service Award HL-10216.
Address for reprint requests and other correspondence: T. L. Clanton, Dorothy Davis Heart and Lung Research Institute, Pulmonary and Critical Care Division, #201, 473 W. 12th, Columbus, OH 43210-1228 (E-mail: clanton.1{at}osu.edu).
| |
REFERENCES |
|---|
|
|
|---|
1.
Abe, J,
and
Berk BC.
Reactive oxygen species as mediators of signal transduction in cardiovascular disease.
Trends Cardiovasc Med
8:
59-64,
1998[ISI].
2.
Asemu, G,
Papousek F,
Ostadal B,
and
Kolar F.
Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial KATP channel.
J Mol Cell Cardiol
31:
1821-1831,
1999[ISI][Medline].
3.
Bailey, DM,
Davies B,
and
Baker J.
Training in hypoxia: modulation of metabolic and cardiovascular risk factors in men.
Med Sci Sports Exerc
32:
1058-1066,
2000[ISI][Medline].
4.
Banchero, N.
Long term adaptation of skeletal muscle capillarity.
Physiologist
25:
383-387,
1982.
5.
Bender, PR,
Groves BM,
McCullough RE,
McCullough RG,
Trad L,
Young AJ,
Cymerman A,
and
Reeves JT.
Decreased exercise muscle lactate release after high altitude acclimatization.
J Appl Physiol
67:
1456-1462,
1989
6.
Boning, D.
Altitude and hypoxia training
a short review.
Int J Sports Med
18:
565-570,
1997[ISI][Medline].
7.
Boutellier, U,
Howald H,
di Prampero PE,
Giezendanner D,
Cerretelli D,
and
Cerretelli P.
Human muscle adaptations to chronic hypoxia.
In: Hypoxia, Exercise and Altitude, edited by Sutton JR,
Houston CD,
and Jones N.. New York: Liss, 1983, p. 273-281.
8.
Brooks, GA,
Butterfield DA,
Wolfe RR,
Groves BM,
Masseo RS,
Sutton JR,
Wolfel EE,
and
Reeves JT.
Decreased reliance on lactate during exercise after acclimatization to 4,300 m.
J Appl Physiol
71:
333-341,
1991
9.
Brooks, GA,
Butterfield GE,
Wolfe RR,
Groves BM,
Masseo RS,
Sutton JR,
Wolfel EE,
and
Reeves JT.
Increased dependence on glucose after acclimatization to 4,300 m.
J Appl Physiol
70:
919-927,
1991
10.
Bunn, HF,
and
Poyton RO.
Oxygen sensing and molecular adaptation to hypoxia.
Physiol Rev
76:
839-895,
1996
11.
Bylund, AC,
Hammarsten J,
Holm J,
and
Schersten T.
Enzyme activities in skeletal muscles from patients with peripheral arterial insufficiency.
Eur J Clin Invest
6:
425-429,
1976[ISI][Medline].
12.
Bylund-Fellenius, AC,
Idstrom JP,
and
Holm S.
Muscle respiration during exercise.
Am Rev Respir Dis
129:
S10-S12,
1984[ISI][Medline].
13.
Bylund-Fellenius, AC,
Walker PM,
Elander A,
Holm S,
Holm J,
and
Schersten T.
Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise.
Biochem J
200:
247-255,
1981[ISI][Medline].
14.
Ceretelli, P.
Muscle energetics and ultrastructure in chronic hypoxia.
Respiration
59:
24-29,
1992.
15.
Cerretelli, P.
Limiting factors to oxygen transport on Mount Everest.
J Appl Physiol
40:
658-667,
1976
16.
Chandel, NS,
McClintock DS,
Feliciano CE,
Wood TM,
Melendez JA,
Rodriguez AM,
and
Schumacker PT.
Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor 1
during hypoxia: a mechanism for O2 sensing.
J Biol Chem
275:
25130-25138,
2000
17.
Clanton, TL,
Wright VP,
Reiser PJ,
Klawitter PF,
and
Prabhakar NR.
Improved anoxic tolerance in rat diaphragm following intermittent hypoxia.
J Appl Physiol
90:
2508-2513,
2001
18.
Clyne, CA,
Mears H,
Weller RO,
and
O'Donnell TF.
Calf muscle adaptation to peripheral vascular disease.
Cardiovasc Res
19:
507-512,
1985[ISI][Medline].
19.
Cohen, MV,
Baines CP,
and
Downey JM.
Ischemic preconditioning: from adenosine receptor to KATP channel.
Annu Rev Physiol
62:
79-109,
2000[ISI][Medline].
20.
Connett, RJ,
Honig CR,
Gayeski TEJ,
and
Brooks GA.
Defining hypoxia: a systems view of
O2, glycolysis, energetics, and intracellular PO2.
J Appl Physiol
68:
833-842,
1990
21.
Derave, W,
and
Hespel P.
Role of adenosine in regulating glucose uptake during contractions and hypoxia in rat skeletal muscle.
J Physiol (Lond)
515:
255-263,
1999
22.
Duranteau, J,
Chandel NS,
Kulisz A,
Shao Z,
and
Schumacker PT.
Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes.
J Biol Chem
273:
11619-11624,
1998
23.
Elander, A,
Idstrom JP,
Holm S,
Schersten T,
and
Bylund-Fellenius AC.
Metabolic adaptation to reduced muscle blood flow. II. Mechanisms and beneficial effects.
Am J Physiol Endocrinol Metab
249:
E70-E76,
1985
24.
Elander, A,
Idstrom JP,
Schersten T,
and
Bylund-Fellenius AC.
Metabolic adaptation to reduced muscle blood flow. I. Enzyme and metabolite alterations.
Am J Physiol Endocrinol Metab
249:
E63-E69,
1985
25.
Elsner, R,
Oyasaeter S,
Almaas R,
and
Saugstad OD.
Diving seals, ischemia-reperfusion and oxygen radicals.
Comp Biochem Physiol A Physiol
119:
975-980,
1998.
26.
Eu, JP,
Sun J,
Xu L,
Stamler JS,
and
Meissner G.
The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions.
Cell
102:
499-509,
2000[ISI][Medline].
27.
Fletcher, EC.
Effect of episodic hypoxia on sympathetic activity and blood pressure.
Respir Physiol
119:
189-197,
2000[ISI][Medline].
28.
Fletcher, EC,
Lesske J,
Qian W,
Miller CCI,
and
Unger T.
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.
Hypertension
19:
555-561,
1992
29.
Franch, J,
Aslesen R,
and
Jensen J.
Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase.
Biochem J
344:
231-235,
1999.
30.
Gardner, PR,
Nguyen DDH,
and
White CW.
Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs.
Proc Natl Acad Sci USA
91:
12248-12252,
1994
31.
Gasbarrini, A,
Colantoni A,
DiCampli C,
De Notariis S,
Masetti M,
Iovine E,
Mazziotti A,
Massari I,
Gasbarrini G,
Pola P,
and
Bernardi M.
Intermittent anoxia reduces oxygen free radicals formation during reoxygenation in rat hepatocytes.
Free Radic Biol Med
23:
1067-1072,
1997[ISI][Medline].
32.
Gasser, R,
Schafhalter-Zoppoth I,
Schwarz T,
Eber B,
Koppel H,
Lechleitner P,
Puschendorf B,
Dienstl F,
and
Klein W.
Cyclic phenomena in early myocardial infarction.
Acta Med Austriaca
22:
69-72,
1995[ISI][Medline].
33.
Gosker, HR,
Wouters EF,
van der Vusse GJ,
and
Schols AM.
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure; underlying mechanism and therapy perspectives.
Am J Clin Nutr
71:
1033-1047,
2000
34.
Green, HJ,
MacDougall J,
Tarnopolsky M,
and
Melissa NL.
Downregulation of Na+-K+-ATPase pumps in skeletal muscle with training in normobaric hypoxia.
J Appl Physiol
86:
1745-1748,
1999
35.
Green, HJ,
Sutton JR,
Cymerman A,
Young PM,
and
Houston CS.
Operation Everest II: adaptations in human skeletal muscle.
J Appl Physiol
66:
2454-2461,
1989
36.
Green, HJ,
Sutton JR,
Wolfel EE,
Reeves JT,
Butterfield GE,
and
Brooks GA.
Altitude acclimatization and energy metabolic adaptation in skeletal muscle during exercise.
J Appl Physiol
73:
2701-2708,
1992
37.
Green, HJ,
Sutton JR,
Young P,
Cymerman A,
and
Houston CS.
Operation Everest II: muscle energetics during maximal exhaustive exercise.
J Appl Physiol
66:
142-150,
1989
38.
Gustafsson, T,
Puntschart A,
Kaijser L,
Jansson E,
and
Sundberg CJ.
Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle.
Am J Physiol Heart Circ Physiol
276:
H679-H685,
1999
39.
Gutierrez, G,
Marini C,
Acero AL,
and
Lund N.
Skeletal muscle PO2 during hypoxemia and isovolemic anemia.
J Appl Physiol
68:
2047-2053,
1990
40.
Han, XX,
and
Bonen A.
Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle.
Am J Physiol Endocrinol Metab
274:
E700-E707,
1998
41.
Hayes, DJ,
Challiss RAJ,
and
Radda GK.
An investigation of arterial insufficiency in rat hindlimb: an enzymatic, mitochondrial and histological study.
Biochem J
236:
469-473,
1986[ISI][Medline].
42.
Hochachka, PW.
The lactate paradox: analysis of underlying mechanisms.
Ann Sports Med
4:
184-188,
1988.
43.
Hochachka, PW,
Stanley C,
Merkt J,
and
Sumar-Kalinowski J.
Metabolic meaning of elevated levels of oxidative enzymes in high altitude adapted animals: an interpretive hypothesis.
Respir Physiol
52:
303-313,
1982.
44.
Holm, H,
Bjorntorp P,
and
Schersten T.
Metabolic activity in rat skeletal muscle: effect of intermittent hypoxia.
Eur J Clin Invest
3:
279-283,
1973[ISI][Medline].
45.
Howald, H,
Pette D,
Simoneau JA,
Uber A,
Hoppeler H,
and
Cerretelli P, III.
Effects of chronic hypoxia on muscle enzyme activities.
Int J Sports Med
11:
S10-S14,
1990.
46.
Hwa, JJ,
Ghibaudi L,
Compton D,
Fawzi AB,
and
Strader CD.
Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice.
Horm Metab Res
28:
659-663,
1996[ISI][Medline].
47.
Jackson, DC.
Living without oxygen: lessons from the freshwater turtle.
Comp Biochem Physiol A Physiol
125:
299-315,
2000.
48.
Javeshghani, D,
Sakkal D,
Mori M,
and
Hussain SN.
Diaphragmatic nitric oxide synthase expression during hypobaric hypoxia.
Am J Physiol Lung Cell Mol Physiol
279:
L520-L527,
2000
49.
Jiang, BH,
Semenza GL,
Bauer C,
and
Marti HH.
Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension.
Am J Physiol Cell Physiol
271:
C1172-C1180,
1996
50.
Jones, DP.
Intracellular diffusion gradients of O2 and ATP.
Am J Physiol Cell Physiol
250:
C663-C675,
1986
51.
Kacimi, R,
Chentoufi J,
Honbo N,
Long CS,
and
Karliner JS.
Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection.
Cardiovasc Res
46:
139-150,
2000
52.
Kasalicky, J,
Ressl J,
Urbanova D,
Widimsky J,
Ostadal B,
Pelouch V,
Vizek M,
and
Prochazka J.
Relative organ blood flow in rats exposed to intermittent high altitude hypoxia.
Pflügers Arch
368:
111-115,
1977[ISI][Medline].
53.
Katayama, K,
Sato Y,
Mrotome Y,
Shima N,
Ishida K,
Mori S,
and
Miyamura M.
Ventilatory chemosensitive adaptations to intermittent hypoxic exposure with endurance training and detraining.
J Appl Physiol
86:
1805-1811,
1999
54.
Katz, A,
Broberg S,
Sahlin K,
and
Wahren J.
Leg glucose uptake during maximal dynamic exercise in humans.
Am J Physiol Endocrinol Metab
251:
E65-E70,
1986
55.
Kraiczi, H,
Magga J,
Sun XY,
Ruskoaho H,
Zhao X,
and
Hedner J.
Hypoxic pressor response, cardiac size and natriuretic peptides are modified by long-term intermittent hypoxia.
J Appl Physiol
87:
2025-2031,
1999
56.
Krieger, J,
Laks L,
Wilcox I,
Grunstein RR,
Costas LJ,
McDougall JG,
and
Sullivan CE.
Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnea before and during treatment with nasal continuous positive airway pressure.
Clin Sci (Colch)
77:
407-411,
1989.
57.
Kuno, S,
Inaki M,
Tanaka K,
Itai Y,
and
Asano K.
Muscle energetics in short-term training during hypoxia in elite combination skiers.
Eur J Appl Physiol
69:
301-304,
1994.
58.
Liu, Y,
Steinacker JM,
and
Strauch M.
Transcutaneous oxygen tension and doppler ankle pressure during upper and lower body exercise in patients with peripheral arterial occlusive disease.
Angiology
46:
689-698,
1995.
59.
Lundgren, F,
Dahllof AG,
Schersten T,
and
Bylund-Fellenius AC.
Muscle enzyme adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of different treatments and consequences on walking performance.
Clin Sci (Colch)
77:
485-493,
1989.
60.
Maltais, F,
Sullivan MJ,
LeBlanc P,
Duscha BD,
Schachat FH,
Simard C,
Blank JM,
and
Jobin J.
Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD.
Eur Respir J
13:
850-854,
1999[Abstract].
61.
McNulty, PH,
Ng C,
Liu WX,
Jagasia D,
Letsou GV,
Baldwin JC,
and
Soufer R.
Autoregulation of myocardial glycogen concentration during intermittent hypoxia.
Am J Physiol Regulatory Integrative Comp Physiol
271:
R311-R319,
1996
62.
Melissa, L,
MacDougall JD,
Tarnopolsky MA,
Cipriano N,
and
Green HJ.
Skeletal muscle adaptation to training under normobaric hypoxic versus normoxic conditions.
Med Sci Sports Exerc
29:
238-243,
1997[ISI][Medline].
63.
Mizuno, M,
Juel C,
Bro-Rasmussen T,
Mygind E,
Schibye B,
Rasmussen B,
and
Saltin B.
Limb skeletal muscle adaptation in athletes after training at altitude.
J Appl Physiol
68:
496-502,
1990
64.
Mohanraj, P,
Merola AJ,
Wright VP,
and
Clanton TL.
Antioxidants protect rat diaphragmatic muscle function under hypoxic conditions.
J Appl Physiol
84:
1960-1966,
1998
65.
Murry, CE,
Jennings RB,
and
Reimer KA.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation
74:
1124-1136,
1986
66.
Narkiewicz, K,
van de Borne PJ,
Cooley RL,
Dyken ME,
and
Somers VK.
Sympathetic activity in obese subjects with and without obstructive sleep apnea.
Circulation
98:
772-776,
1998
67.
Narkiewicz, K,
van de Borne PJ,
Pesek CA,
Dyken ME,
Montano N,
and
Somers VK.
Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea.
Circulation
99:
1183-1189,
1999
68.
Navegantes, LC,
Resano NM,
Migliorini RH,
and
Kettelhut IC.
Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle.
Am J Physiol Endocrinol Metab
279:
E663-E668,
2000